Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
153,159,065
-
Total 13F shares
-
35,612,549
-
Share change
-
-17,768,890
-
Total reported value
-
$10,048,893
-
Price per share
-
$0.28
-
Number of holders
-
40
-
Value change
-
-$8,584,445
-
Number of buys
-
13
-
Number of sells
-
38
Institutional Holders of BIODESIX INC - Common Stock, par value $0.001 per share (BDSX) as of Q2 2025
As of 30 Jun 2025,
BIODESIX INC - Common Stock, par value $0.001 per share (BDSX) was held by
40 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
35,612,549 shares.
The largest 10 holders included
Telemark Asset Management, LLC, Wilmington Savings Fund Society, FSB, Birchview Capital, LP, VANGUARD GROUP INC, PERCEPTIVE ADVISORS LLC, Monashee Investment Management LLC, SILVERARC CAPITAL MANAGEMENT, LLC, PERKINS CAPITAL MANAGEMENT INC, GSA CAPITAL PARTNERS LLP, and Balyasny Asset Management L.P..
This page lists
40
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.